NO group | Eosinophil count group | Airway responsiveness FEV1 group | Airway responsiveness resistance group | |||||
---|---|---|---|---|---|---|---|---|
+a n = 44 | -a n = 274 | +b n = 44 | -b n = 274 | +c n = 44 | -c n = 274 | +d n = 27 | -d n = 291 | |
Rhinoconjunctivitis-like symptoms | 6.5% (3) | 9.2% (25) | 9.1% (4) | 8.8% (24) | 4.6% (2) | 9.5% (26) | 11.1% (3) | 8.6% (25) |
p = 0.78 | p = 1.00 | p = 0.40 | p = 0.72 | |||||
Asthma-like symptoms | 6.5% (3) | 1.8% (5) | 4.6% (2) | 2.2% (6) | 0.0% (0) | 2.9% (8) | 3.7% (1) | 2.4% (7) |
p = 0.09 | p = 0.31 | p = 0.61 | p = 0.51 | |||||
MBC test | ||||||||
(Pre – post-test)/pretest FEV1[%] | −9.9 [− 14.8;-5.4] | −5.8 [− 10.0;-3.1] | −7.5 [− 12.2;-3.6] | −6.2 [− 11.2;-3.6] | −18.9 [− 26.0;-17.2] | −5.5 [− 8.7;-2.9] | −9.8 [− 16.7;-7.9] | −5.8 [− 11.0;-3.4] |
p = 0.0009 | p = 0.59 | e | p = 0.0015 | |||||
(Post– pretest)/pretest Rrs4–16 [%] | 17.7 [10.7;34.0] | 15.8 [6.5;29.0] | 14.4 [5.3;28.3] | 16.1 [6.8;29.7] | 24.9 [12.7;37.2] | 15.0 [6.4;26.4] | 63.6 [53.0;77.2] | 14.6 [6.4;24.1] |
p = 0.16 | p = 0.63 | p = 0.0017 | e | |||||
Eosinophil count | ||||||||
Eosinophil count < 1 86.2% (274) | 69.6% (32) | 89.0% (242) | – | 100.0% (274) | 81.8% (36) | 86.9% (238) | 88.9% (24) | 86.0% (250) |
p < 0.0005 | e | p = 0.35 | p = 1.0 | |||||
Eosinophil count [%] if ≥1% | 32.5 [15.0;60.0] | 9.5 [3.6;20.0] | 13.9 [5.2;30.9] | – | 37.0 [15.1;65.7] | 11.9 [4.9;23.3] | 60.0 [16.7;80.0] | 12.0 [5.0;26.6] |
p = 0.006 | e | p = 0.063 | p = 0.07 | |||||
FeNO [ppb] | 45.4 [34.0;64.1] | 11.8 [8.7;16.0] | 17.0 [10.2;45.5] | 12.3 [9.0;17.4] | 17.2 [10.4;30.7] | 12.3 [8.9;17.6] | 17.2 [11.0;33.2] | 12.5 [9.0;17.9] |
e | p = 0.0029 | p = 0.0042 | p = 0.02 |